SYNCHRONOUS HAIRY CELL LEUKEMIA AND HEPATOCELLULAR CARCINOMA: A CASE REPORT
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18302Keywords:
diagnostic difficulties, multiple primary malignancies, pulmonary embolismAbstract
Multiple primary malignant tumors are characterized by independent occurrence and development of two or more malignant neoplasms in the same patient. We present an extremely rare case of synchronous double primary malignancies, hairy cell leukemia and hepatocellular carcinoma with lethal outcome. Diagnosis of hepatocellular carcinoma was difficult due to the presence of lymphoproliferative disease, which complicated the visualization of the process using ultrasonography. Carcinomatous emboli of hepatocellular carcinoma in small pulmonary arteries without the formation of metastatic foci have led to clinical manifestations typical of pulmonary embolism, pulmonary hypertension and severe respiratory failure. In lymphoproliferative diseases it is necessary to take into account the possibility of the development of another malignant neoplasm, which can be “buried” by tumor infiltration.
References
Parekh J D, Kukrety S, Thandra A, Valenta C. Multiple primary malignant neoplasms in an elderly patient. Cureus 2018; 10: e2384. https://doi.org/10.7759/cureus.2384
Lv M, Zhang X, Shen Y, et al. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors. Medicine (Baltimore) 2017; 96: e6799. https://doi.org/10.1097/MD.0000000000006799
Nemes A, Todor N, Nagy V. Follow-up protocol for oncological patients at risk of developing multiple primary neoplasms. JBUON 2020; 25: 2117–22. PMID: 33099962
Sovgirya SN, Starchenko II, Proskurnia SA, et al. Clinical description of the rare case of polyneoplasia: B-cell lymphoma and bronhioloalveolar carcinoma. World Med Biol 2017; 2: 113–6 (in Russian).
Liu Z, Liu C, Guo W, et al. Clinical analysis of 152 cases of multiple primary malignant tumors in 15,398 patients with malignant tumors. PLOS One 2015; 10: e0125754. https://doi.org/10.1371/journal.pone.0125754
Radzishevska YB, Vasil’ev LY, Knigavko VG, Lykhovitskaya NI. Relationships of nosological form of the primary and second neoplasms in oncological patients. Novosti Khirurgii 2017; 25: 613–20. https://doi.org/10.18484/2305-0047.2017.6.613
Filenko BM, Roiko NV, Stepanchuk AP, et al. Immunohistochemical description of proliferative activity and apoptosis of lung squamous cell carcinoma (literature review). Wiadomosci lekarskie 2016; 69: 289–94. PMID: 27487551 (in Russian).
Filenko BM, Starchenko II, Royko NV, et al. Clinicomorphological observation of refractory hepatoblastoma: a case report. Exp Oncol 2020; 42: 245–7. https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-3.14855
Kryzhanivska AE, Dyakiv IB, Kyshakevych I. Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors. Exp Oncol 2018; 40: 124–7. PMID: 29949531
Price LC, Seckl MJ, Dorfmüller P, Wort SJ. Tumoral pulmonary hypertension. Eur Respir Rev 2019; 28: 180065. https://doi.org/10.1183/16000617.0065-2018
Morita S, Kamimura K, Abe H, et al. Pulmonary tumor thrombotic microangiopathy of hepatocellular carcinoma: A case report and review of literature. World J Gastroenterol 2019; 25: 6949–58. https://doi.org/10.3748/wjg.v25.i48.6949
Zheng G, Chattopadhyay S, Sud A, et al. Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients. Blood Cancer J 2019; 9: 40. https://doi.org/10.1038/s41408-019-0201-0
Murković M., Valković T. Multiple malignant tumors in patient with hairy cell leukemia: case report. Medicina Flum 2018; 54: 433–7. https://doi.org/10.21860/medflum2018207364 (in Croatian).
Skrypnyk I, Maslova G, Lymanets T, et al. How to improve quality of life in patients with acute leukemia and comorbid ischemic heart disease treated with anthracycline-based induction chemotherapy. Exp Oncol 2019; 41: 353–6. https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-4.13906
Skrypnyk I, Maslova G, Lymanets T, et al. L-arginine is an effective medication for prevention of endothelial dysfunction, a predictor of anthracycline cardiotoxicity in patients with acute leukemia. Exp Oncol 2017; 39: 308–11. PMID: 29284775
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
